Isotope-Labeled Compounds

Primidone-d5 is a deuterium-labeled analog of Primidone, primarily known for its inhibitory action on the transient receptor potential melastatin 3 (TRPM3) channel, with an IC50 value of 0.6 μM. This reagent also inhibits receptor-interacting protein (RIP) kinase and voltage-gated sodium channels, while acting as an antagonist at the GABA receptor. Primidone-d5 is valuable for research in pain management and seizure disorders, enabling studies focused on its analgesic and anticonvulsant properties.

Cystamine-d8 dihydrochloride is a deuterated form of Cystamine (dihydrochloride), serving as a stable isotope for precise experimental applications. It functions as an inhibitor of transglutaminase (Tgase) and demonstrates inhibition of caspase-3 with an IC50 value of 23.6 μM. This reagent is particularly valuable in research related to neurodegenerative diseases, including Huntington's disease, facilitating studies on the molecular mechanisms underlying these conditions.

Tauroursodeoxycholate-d4-1 is a deuterium-labeled derivative of Tauroursodeoxycholate, an endoplasmic reticulum (ER) stress inhibitor. This compound has been shown to significantly decrease the expression of pro-apoptotic molecules, including caspase-3 and caspase-12, thereby contributing to cell survival under stress conditions. Additionally, Tauroursodeoxycholate inhibits extracellular signal-regulated kinase (ERK), making it a valuable tool for research applications focused on ER stress and cell signaling pathways.

Fenbufen-d9 is a deuterium-labeled derivative of Fenbufen, a non-steroidal anti-inflammatory drug (NSAID) exhibiting potent antipyretic effects. It targets cyclooxygenase enzymes COX-1 and COX-2, demonstrating inhibitory activities with IC50 values of 3.9 μM and 8.1 μM, respectively. Fenbufen has shown significant efficacy in various preclinical animal models, including carrageenan-induced edema, UV erythema, and adjuvant arthritis. Additionally, it inhibits multiple caspases (caspase-1, 3, 4, 5, 9), making it a valuable tool for research in inflammation and apoptosis.

Lacidipine-13C8 is a deuterium-labeled derivative of Lacidipine, a highly selective L-type calcium channel blocker that primarily targets smooth muscle cells. This compound is known for its ability to dilate peripheral arteries, thereby reducing peripheral resistance and providing sustained antihypertensive effects. Lacidipine has also demonstrated protective effects on human kidney cells by modulating the caspase-3 pathway in response to ATP depletion. It is applicable in research related to hypertension, atherosclerosis, and acute kidney injury (AKI).

PAC-1-d8 is a deuterium-labeled form of Procaspase Activating Compound 1, specifically designed as a stable isotope. This compound activates procaspase-3, leading to apoptosis in cancer cells, with an EC50 value of 2.08 μM. PAC-1-d8 is primarily used in research applications aimed at studying apoptotic pathways and evaluating therapeutic strategies for cancer treatment.

2'-Deoxyadenosine-15N1 is a stable isotope-labeled variant of 2'-Deoxyadenosine, primarily utilized in metabolic labeling studies. It exerts a biological effect by inhibiting glucose-stimulated insulin release and impeding cAMP accumulation in pancreatic islets. Additionally, 2'-Deoxyadenosine-15N1 activates caspase-3, promoting apoptosis, and inhibits the enzyme S-adenosyl-L-homocysteine hydrolase (SAHH). Its cell growth inhibition properties suggest potential applications in cancer research, particularly in studying its effects on colon cancer cell lines.

Necrosulfonamide-d4 is a deuterium-labeled variant of Necrosulfonamide, a potent inhibitor of MLKL and Gasdermin D (GSDMD). This compound specifically targets the downstream oligomerization step of necroptosis and pyroptosis without affecting upstream signaling pathways. By attenuating the expression of pivotal kinases such as NLRP3 and caspase-1, Necrosulfonamide-d4 modulates inflammatory responses and activates the Nrf2 pathway, enhancing antioxidant enzyme activity. This reagent is valuable for research applications involving neurodegenerative diseases, inflammatory conditions, tissue damage, and programmed necrosis pathways.

Tauroursodeoxycholate-d4 is a deuterated form of Tauroursodeoxycholate, serving as an endoplasmic reticulum (ER) stress inhibitor. This compound effectively reduces the expression of apoptosis-related molecules, including caspase-3 and caspase-12, thereby influencing cell survival pathways. Additionally, Tauroursodeoxycholate-d4 inhibits the extracellular signal-regulated kinase (ERK) pathway, making it valuable for research into cellular stress responses and related therapeutic applications.

Tauroursodeoxycholate-d5 is a deuterium-labeled derivative of Tauroursodeoxycholate, an endoplasmic reticulum (ER) stress inhibitor. This compound effectively reduces the expression of apoptosis-related proteins, including caspase-3 and caspase-12, while also inhibiting the extracellular signal-regulated kinase (ERK) pathway. Tauroursodeoxycholate-d5 is valuable for tracing biological processes in studies related to ER stress and cellular apoptosis.

2'-Deoxyadenosine-13C10,15N5 is a stable isotope-labeled form of 2'-Deoxyadenosine that features 13C and 15N isotopes. This nucleoside is known to inhibit glucose-stimulated insulin release and attenuates increases in cyclic AMP (cAMP) accumulation in islet cells. Additionally, 2'-Deoxyadenosine activates caspase-3, promoting apoptosis, and inhibits S-adenosyl-L-homocysteine hydrolase (SAHH) activity. This compound also exhibits growth inhibitory effects on various cell types and demonstrates anticancer activity against colon cancer, making it a valuable tool for biochemical and pharmaceutical research.

Terfenadine-d3 is the deuterated form of Terfenadine, which primarily targets the hERG potassium channel as a potent open-channel blocker with an IC50 of 204 nM. As an H1 histamine receptor antagonist, Terfenadine-d3 demonstrates significant biological activity by inducing apoptosis in melanoma cells through the modulation of calcium homeostasis. Its mechanism includes the generation of reactive oxygen species (ROS) and the subsequent activation of caspases -4, -2, and -9, making it valuable for research in cancer biology and apoptosis pathways.

Fenobucarb-d3 is a deuterium-labeled derivative of Fenobucarb, a carbamate insecticide known to induce neurotoxicity in zebrafish models. This compound operates through mechanisms involving inflammation, oxidative stress, and apoptotic degeneration. Research applications include studying the toxicological effects of insecticides on developmental processes and evaluating potential risks to cardiovascular and cerebrovascular systems in animal models.

2'-Deoxyadenosine monohydrate-5′-13C is a stable isotope-labeled form of 2'-Deoxyadenosine monohydrate, primarily targeting cellular metabolism and signaling pathways. This compound inhibits glucose-stimulated insulin release by blocking the increase of cyclic AMP (cAMP) in pancreatic islets and activating caspase-3, thereby promoting apoptosis. Additionally, it inhibits S-adenosyl-L-homocysteine hydrolase (SAHH) activity and demonstrates growth-inhibitory effects on various cell types, exhibiting potential anticancer properties, particularly against colon cancer. These characteristics make it a valuable tool for studies in metabolic regulation and cancer research.

2'-Deoxyadenosine monohydrate-13C10,15N5 hydrate is a stable isotope-labeled variant of 2'-Deoxyadenosine monohydrate, incorporating both carbon-13 and nitrogen-15. This nucleoside is known to inhibit glucose-stimulated insulin release by affecting islet cyclic AMP (cAMP) levels. Additionally, it activates caspase-3, promoting apoptosis, and demonstrates inhibition of S-adenosyl-L-homocysteine hydrolase (SAHH). Research applications include studying cellular growth inhibition and evaluating anticancer effects, particularly in colon cancer models.

Aspirin-d3 is a deuterium-labeled derivative of aspirin (acetylsalicylic acid) that serves as a stable isotope for research applications. This compound acts as a potent and irreversible inhibitor of cyclooxygenases COX-1 and COX-2, with IC50 values of 5 and 210 μg/mL, respectively. Aspirin-d3 is utilized to investigate its apoptotic effects and to study the inhibition of NF-κB activation. Additionally, it plays a role in exploring the inhibition of platelet prostaglandin synthetase, contributing to research on coronary artery and cerebrovascular thrombosis.

Acetyl-L-carnitine-d3 hydrochloride is a deuterium-labeled derivative of Acetyl-L-carnitine that targets mitochondrial energy metabolism. It acts as a neuroprotective agent capable of crossing the blood-brain barrier, enhancing energy metabolism, and reducing oxidative stress. This compound is utilized in research related to neurodegenerative diseases, metabolic disorders, and conditions like Alzheimer's disease and depression, contributing to studies on synaptic plasticity and neuronal protection. Its properties make it a valuable tool for investigating the biochemical pathways associated with cellular energy regulation and neuroprotection.

2'-Deoxyadenosine monohydrate-1′-13C is a stable isotope-labeled version of 2'-Deoxyadenosine monohydrate that primarily targets nucleotide metabolism. This compound exhibits significant biological activity by inhibiting glucose-stimulated insulin release and decreasing cyclic AMP (cAMP) accumulation in pancreatic islets. Additionally, it activates caspase-3, promoting apoptotic processes, and inhibits S-adenosyl-L-homocysteine hydrolase (SAHH), thereby impacting cell growth. Its potential anticancer properties have been observed in colon cancer research, making it a valuable tool for investigations into nucleotide signaling and cancer biology.

Moroxydine hydrochloride-d8 is a stable isotope-labeled derivative of Moroxydine, a broad-spectrum antiviral agent targeting both DNA and RNA viruses. It demonstrates potent antiviral activity against various pathogens, including influenza, herpes simplex, varicella zoster, and hepatitis C virus, while maintaining low cytotoxicity in infected cells. Research has shown that Moroxydine hydrochloride inhibits cytopathic effects induced by dsRNA and large DNA viruses, effectively preserving the morphological integrity of affected cells and significantly reducing apoptosis markers and pro-apoptotic factors. This compound is valuable for studies investigating antiviral mechanisms and drug efficacy in viral infections.

Hydroquinone-d4 is a deuterium-labeled derivative of Hydroquinone, primarily used as a stable isotope for research applications. Hydroquinone is a known antioxidant with significant biological activity, implicated in enhancing carcinogenic risk through DNA damage generation. It promotes tumor cell proliferation while suppressing the immune response and induces apoptosis in leukocytes via the mitochondrial pathway (Caspase 9/3). Additionally, hydroquinone exhibits increased toxicity to aquatic organisms, presenting a complex profile in environmental studies.

Tauroursodeoxycholate-d4 sodium is a deuterium-labeled derivative of Tauroursodeoxycholic acid (TUDCA), serving as a stable isotope for research purposes. Primarily functioning as an endoplasmic reticulum (ER) stress inhibitor, Tauroursodeoxycholate demonstrates the ability to significantly reduce the expression of pro-apoptotic molecules, including caspase-3 and caspase-12, thereby mitigating ER stress-related apoptosis. Additionally, it has been shown to inhibit extracellular signal-regulated kinase (ERK) activity, making it valuable for studies investigating cellular stress responses and related pathways.

Tryptophol-d4 is a deuterium-labeled derivative of Tryptophol, functioning primarily as a stable isotope for research applications. This compound exhibits significant biological activities, including the induction of apoptosis through caspase-8 cleavage, inhibition of Cunninghamella blakesleeana biofilm formation, and modulation of immune responses. Its diverse applications extend to the investigation of sleep disorders, epilepsy, and African trypanosomiasis, providing valuable insights into these areas of study.

Acetyl-L-carnitine-d3-1 hydrochloride is a deuterium-labeled derivative of Acetyl-L-carnitine hydrochloride, functioning as a stable isotope. This compound serves as a mitochondrial energy metabolism regulator and neuroprotectant capable of traversing the blood-brain barrier. It selectively enters cells via the organic cation transporter OCTN2 and participates in fatty acid β-oxidation, promotes acetylcholine synthesis, and regulates mitochondrial function while mitigating oxidative stress. Acetyl-L-carnitine-d3-1 hydrochloride is primarily utilized in research on neurodegenerative diseases and metabolic disorders, including Alzheimer's disease and neonatal hypoxic-ischemic brain damage.

Aspirin-d4 is a deuterium-labeled form of Aspirin (Acetylsalicylic acid), functioning as a stable isotope for various biochemical applications. It acts as a potent and irreversible inhibitor of cyclooxygenase enzymes COX-1 and COX-2, demonstrating IC50 values of 5 and 210 μg/mL, respectively. Aspirin-d4 triggers apoptosis and inhibits NF-κB activation, while also affecting platelet function through the inhibition of prostaglandin synthetase. This reagent is suitable for studies involving inflammation, cardiovascular research, and cellular signaling pathways.

rel-(1S,2R)-Dihydro bupropion-d9 hydrochloride is a deuterated form of rel-(1S,2R)-Dihydro bupropion hydrochloride, a metabolite of the widely known antidepressant bupropion. This compound is a stable isotope that facilitates studies on cytokine modulation, specifically promoting endogenous IL-10 production while inhibiting Th1 cytokines such as IL-12 and TNF-α. Additionally, rel-(1S,2R)-Dihydro bupropion influences immune response dynamics, shifting from a Th1 to Th2 response. It is valuable for research focused on inflammatory conditions and immunological response pathways.

rel-(1S,2R)-Dihydro bupropion-d9 is a deuterium-labeled analog of rel-(1S,2R)-Dihydro bupropion, a key metabolite of the antidepressant bupropion. This compound functions by promoting endogenous interleukin-10 (IL-10) production while inhibiting Th1 cytokines, such as IL-12 and TNF-α, facilitating a shift in immune responses from Th1 to Th2. rel-(1S,2R)-Dihydro bupropion-d9 is valuable for research into inflammatory conditions and immune modulation.

Lubiprostone-d7 is a deuterated form of Lubiprostone, targeting the CIC-2/CFTR pathways to enhance intestinal fluid secretion. This compound is notable for its ability to inhibit myeloperoxidase (MPO) activity and downregulate the expression of iNOS and TNFα induced by Indomethacin. Lubiprostone-d7 is primarily utilized in research applications focused on chronic constipation and gastrointestinal disorders, providing a stable isotope for in-depth biochemical analysis.

Apremilast-d3 is a deuterated form of Apremilast, an orally bioavailable inhibitor of type-4 cyclic nucleotide phosphodiesterase (PDE-4) with an IC50 of 74 nM. By inhibiting PDE-4, Apremilast-d3 effectively reduces the release of TNF-α in response to lipopolysaccharide (LPS), exhibiting an IC50 of 104 nM. This stable isotope-labeled reagent is valuable for quantitative studies in pharmacokinetics and metabolic research related to inflammatory conditions.

Apremilast-d8 is a deuterium-labeled derivative of Apremilast, an orally active inhibitor of type-4 cyclic nucleotide phosphodiesterase (PDE-4) with a reported IC50 of 74 nM. This reagent effectively inhibits the release of tumor necrosis factor-alpha (TNF-α) induced by lipopolysaccharide (LPS), exhibiting an IC50 of 104 nM. Apremilast-d8 is ideal for stable isotope labeling applications in biochemical and pharmacological research, particularly in studies examining PDE-4 inhibition and its effects on inflammatory pathways.

Fosfenopril-d7 is a deuterium-labeled form of Fosfenopril, an angiotensin-converting enzyme (ACE) inhibitor. This stable isotope is utilized in pharmacokinetic studies and metabolic research to investigate drug disposition and interaction mechanisms. Its distinct isotopic signature allows for precise tracking in biological assays, enhancing the understanding of Fosfenopril's efficacy and safety profiles in cardiovascular studies.

Tizanidine-d4 hydrochloride is deuterium labeled Tizanidine hydrochloride. Tizanidine hydrochloride, a skeletal muscle relaxant, is an orally effective central α2-adrenoceptor agonist (IC50 = 6.9 nmol). Tizanidine hydrochloride primarily exerts muscle relaxation effects by inhibiting the release of excitatory amino acids (glutamate and aspartate) from the presynaptic terminals of spinal cord interneurons. Tizanidine hydrochloride has anti-injury activity and can inhibit gastrointestinal (GI) transport. Tizanidine hydrochloride can inhibit the proliferation, migration, and invasion of lung cancer cells and induce cell apoptosis by upregulating Nischarin and inhibiting the AKT and Wnt3a/β-catenin signaling pathways. Tizanidine hydrochloride can be used to treat spasticity caused by diseases such as multiple sclerosis (MS), stroke, and spinal cord injury (SCI).

L-Valine-d7 is a deuterium-labeled derivative of L-Valine, primarily used as a stable isotope for research applications. This amino acid plays a crucial role in protein synthesis and metabolism, as well as exhibiting biological activity such as inducing lipid peroxidation and the accumulation of malondialdehyde (MDA). L-Valine has been found to inhibit multidrug-resistant bacteria via the activation of the PI3K/Akt signaling pathway and the inhibition of arginase, making it valuable for studies related to antimicrobial resistance and metabolic pathways.

Tianeptine-d12 is a deuterated analog of Tianeptine, functioning as a stable isotope for research applications. Tianeptine is classified as an atypical antidepressant, acting primarily as a moderate-intensity agonist of the μ-opioid receptor and showing lesser activity at the δ-opioid receptor. This compound modulates glutamate signaling by enhancing AMPA receptor activity while antagonizing NMDA receptors, contributing to its neuroprotective effects under stress and inflammation. Additionally, Tianeptine exhibits anti-inflammatory and antioxidant properties and has been shown to inhibit MMP-9 through the suppression of the PI3K/Akt-mediated NF-κB pathway, making it relevant for studies in depression, anxiety, and neuroprotection.

Cinnamyl Alcohol-d5 is a deuterated form of Cinnamyl Alcohol, a compound that plays a significant role in metabolic studies. This stable isotope serves as an important molecular tracer in research applications, particularly in investigating PPARγ signaling pathways. Cinnamyl Alcohol exhibits notable biological activities, including anti-obesity, antioxidant, and anti-inflammatory effects, making it a valuable tool for studying metabolic disorders and therapeutic interventions.

Bisphenol F-13C12 is a stable isotope-labeled analogue of Bisphenol F, functioning as an orally active endocrine disruptor. It is known to promote reactive oxygen species (ROS) generation, upregulate key signaling proteins such as p-AKT and p-GSK3β, and induce apoptosis, demonstrating significant impact on cellular health. Bisphenol F disrupts glucose metabolism and can impair neurodevelopment and reproductive functions, showing reduced social novelty preference in mouse models. This compound is valuable for research on bone, blood, and adipose tissue, as well as for studies investigating alternatives to Bisphenol A.

Histamine-d4 is a deuterium-labeled derivative of histamine, functioning primarily as a stable isotope for metabolic and pharmacokinetic studies. This compound acts as an agonist at histamine receptors and serves as a notable vasodilator, playing a critical role in local immune responses, intestinal physiological regulation, and neurotransmission. Histamine influences several signaling pathways, including p38 MAPK and Akt, and exhibits diverse biological activities such as anti-inflammatory, antioxidant, and potential antitumor effects. Its applications in research extend to the study of acute myeloid leukemia, malignant melanoma, and renal cell carcinoma, facilitating a deeper understanding of these conditions.

Acenocoumarol-d5 is a deuterium-labeled analog of Acenocoumarol, functioning as a Vitamin K antagonist. This anticoagulant exhibits key biological activities by inhibiting the MAPK/ERK/JNK signaling pathways, reducing the nuclear translocation of NF-κB p65, and activating the Akt/GSK3β signaling pathway. Acenocoumarol-d5 also induces apoptosis in A549 cells and effectively arrests the cell cycle at the S phase, making it useful for various research applications in cancer and cardiovascular studies.

L-Valine-1-13C,15N is a stable isotope-labeled form of L-Valine, where carbon-13 and nitrogen-15 isotopes are incorporated. As a non-linear semiorganic amino acid, L-Valine plays a significant role in various metabolic processes. It is known to induce lipid peroxidation and lead to the accumulation of malondialdehyde (MDA), as well as exhibiting inhibitory effects on cyanobacteria. Additionally, L-Valine has been shown to inhibit multidrug-resistant bacteria through the activation of the PI3K/Akt signaling pathway while also inhibiting arginase activity, making it valuable for research in metabolic and antimicrobial studies.

Histamine-13C5 is a stable isotope-labeled form of histamine, primarily functioning as an agonist for histamine receptors. This organic nitrogen compound plays a critical role in local immune responses, modulates intestinal physiological functions, and acts as a neurotransmitter. Histamine influences the p38 MAPK/Akt signaling pathway and demonstrates antitumor, antioxidant, and anti-inflammatory properties. Research applications of Histamine-13C5 include the investigation of conditions such as acute myeloid leukemia, malignant melanoma, and renal cell carcinoma, facilitating deeper insights into these diseases.

α-Linolenic acid-d14 is a deuterium-labeled derivative of α-Linolenic acid, an essential fatty acid sourced from seed oils. It is critically important for human health as it cannot be synthesized endogenously. α-Linolenic acid has been shown to modulate the PI3K/Akt signaling pathway, influencing thrombotic processes. Its biological activities also include anti-arrhythmic properties, making it relevant in the research of cardiovascular diseases and cancer.

Creosol-d4 is a deuterated derivative of Creosol (2-Methoxy-4-methylphenol), functioning as a stable isotope tracer. This compound serves as an essential chemical intermediate and is studied for its potential as a biofuel, especially from lignocellulosic biomass. Furthermore, Creosol is known for its ability to penetrate the blood-brain barrier, making it a valuable tool in neurobiological research and metabolism studies.

Benazepril-d5 hydrochloride is a deuterium-labeled derivative of Benazepril hydrochloride, functioning as an angiotensin-converting enzyme (ACE) inhibitor. It reduces angiotensin-II production, thereby alleviating oxidative stress and preventing apoptosis through the PI3K/Akt signaling pathway. This compound is instrumental in investigating conditions such as hypertension, heart failure, and diabetic nephropathy, as it has been shown to improve renal function and decrease proteinuria.

Artemisinin-d3 is a deuterium-labeled form of Artemisinin, a sesquiterpene lactone recognized for its potent anti-malarial activity derived from Artemisia annua L. This compound acts by inhibiting the AKT signaling pathway, leading to a dose-dependent reduction in phosphorylated AKT levels. Additionally, Artemisinin demonstrates significant biological effects including the attenuation of cancer cell proliferation, migration, invasion, tumorigenesis, and metastasis, as well as exhibiting neuroprotective properties. This reagent is ideal for studies focused on drug metabolism, pharmacokinetics, and the elucidation of biological mechanisms in cancer and neuroprotection research.

Trimebutine-d5 fumarate is a deuterium-labeled derivative of Trimebutine fumarate, functioning primarily as a multi-target inhibitor and opioid receptor agonist. This compound exhibits key biological activities, including the inhibition of L-type Ca2+ channels and large-conductance calcium-activated potassium channels (BKCa), which regulate calcium influx and potassium efflux. Additionally, Trimebutine-d5 fumarate targets Toll-like receptors, modulating inflammatory signaling pathways, and promotes apoptosis in tumor cells via the AKT/ERK pathway. Its applications are particularly relevant in the study of gastrointestinal disorders, including irritable bowel syndrome (IBS), due to its ability to inhibit excessive smooth muscle contraction.

L-Valine-13C5,15N,d2 is a stable isotope-labeled form of L-Valine, featuring deuterium and carbon-13 and nitrogen-15 isotopes. This compound plays a significant role in metabolic research, particularly in studies investigating lipid peroxidation, as it promotes the accumulation of malondialdehyde (MDA). Furthermore, L-Valine exhibits inhibitory effects against cyanobacteria and multidrug-resistant bacteria through the activation of the PI3K/Akt signaling pathway and the inhibition of arginase. Its utilization in tracer studies enables researchers to explore various biological processes and metabolic pathways.

L-Valine-d1 is a deuterium-labeled derivative of L-Valine, serving as a stable isotope for advanced chemical research. L-Valine is known to induce lipid peroxidation and increase malondialdehyde (MDA) levels, demonstrating significant bioactivity against cyanobacteria. Additionally, it has been shown to inhibit multidrug-resistant bacteria through the activation of the PI3K/Akt signaling pathway and the inhibition of arginase. This compound is valuable in studies exploring metabolic pathways and antimicrobial resistance mechanisms.

L-Valine-2-13C is a stable isotope-labeled form of L-Valine, designed for metabolic studies in biological research. This compound serves as a valuable tracer for examining metabolic pathways and biomolecular interactions. L-Valine has shown biological activities such as promoting lipid peroxidation and inhibiting cyanobacterial growth, as well as exhibiting antimicrobial effects against multidrug-resistant bacteria by activating the PI3K/Akt signaling pathway and inhibiting arginase. Its isotopic labeling makes it a useful tool for quantitative analyses in various biological systems.

Bisphenol F-13C6 is a 13C-labeled form of Bisphenol F, functioning as a stable isotope. This compound acts as an endocrine disruptor, promoting the generation of reactive oxygen species (ROS) while upregulating key signaling proteins, p-AKT and p-GSK3β, ultimately inducing apoptosis. It affects glucose metabolism, neurodevelopment, and reproductive function, and has been shown to reduce social novelty preference in mouse offspring. Bisphenol F-13C6 is valuable for researchers investigating bone, blood, and adipose tissue-related studies, as well as in studies evaluating the effects of bisphenol analogs.

Acenocoumarol-d4 is a deuterated form of Acenocoumarol, functioning primarily as a stable isotope. As an anticoagulant, it operates through Vitamin K antagonism, effectively inhibiting the MAPK/ERK/JNK signaling pathways. This compound has been shown to reduce the nuclear translocation of NF-κB p65 and activate the Akt/GSK3β signaling pathways. Furthermore, Acenocoumarol-d4 induces apoptosis in A549 cells and specifically arrests the cell cycle at the S phase, making it valuable for research in cancer biology and pharmacology.

L-Valine-d1 is a deuterium-labeled derivative of L-Valine, a branched-chain amino acid. It is utilized as a stable isotope for metabolic studies and tracer experiments. L-Valine has been shown to induce lipid peroxidation and increase malondialdehyde (MDA) levels, alongside demonstrating antibacterial properties by inhibiting multidrug-resistant bacteria through the activation of the PI3K/Akt signaling pathway and the inhibition of arginase activity. This reagent is valuable for research in amino acid metabolism, oxidative stress, and drug resistance mechanisms.